(Q46325069)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18843287%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Constitutive JunB expression, associated with the JAK2 V617F mutation, stimulates proliferation of the erythroid lineage (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18843287%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18843287%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Isabelle Plo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18843287%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Irene Lorand-Metze

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18843287%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

William Vainchenker

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18843287%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

B da Costa Reis Monte-Mór

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18843287%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

A F da Cunha

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18843287%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

G G L Costa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18843287%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

D M de Albuquerque

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18843287%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

A Jedidi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18843287%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

S Badaoui

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18843287%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

K B B Pagnano

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18843287%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

S T O Saad

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18843287%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

F F Costa

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18843287%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

9 October 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18843287%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18843287%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18843287%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18843287%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

144-152

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18843287%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2008.275

15 January 2020

exact match

0 references

cites work

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

The regulation of AP-1 activity by mitogen-activated protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

AP1 regulation of proliferation and initiation of apoptosis in erythropoietin-dependent erythroid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

A gain-of-function mutation of JAK2 in myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

Identification of an acquired JAK2 mutation in polycythemia vera

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

Expression of Bcl-x in erythroid precursors from patients with polycythemia vera

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

Constitutive activation of STAT5 and Bcl-xL overexpression can induce endogenous erythroid colony formation in human primary cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

Increased death receptor resistance and FLIPshort expression in polycythemia vera erythroid precursor cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

Activated Jak2 with the V617F point mutation promotes G1/S phase transition

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

Oncogenic kinases of myeloproliferative disorders induce both protein synthesis and G1 activators

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

AP-1 in cell proliferation and survival

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

AP-1 as a regulator of cell life and death

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

AP-1 function and regulation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

A gene activated by growth factors is related to the oncogene v-jun

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

Transcriptional regulatory elements downstream of the JunB gene

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

Activation of junB and c-myc primary response genes by interleukin 9 in a human factor-dependent cell line

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

Induction of junB expression, but not c-jun, by granulocyte colony-stimulating factor or macrophage colony-stimulating factor in the proliferative response of human myeloid leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

Role of JunB in erythroid differentiation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

Chronic Myeloid Leukemia with Increased Granulocyte Progenitors in Mice Lacking JunB Expression in the Myeloid Lineage

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

JunB can substitute for Jun in mouse development and cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

c-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

JunB inhibits proliferation and transformation in B-lymphoid cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

Cell cycle promoting activity of JunB through cyclin A activation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

Derivation of a new hematopoietic cell line with endothelial features from a patient with transformed myeloproliferative syndrome: a case report

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

RGS16 is a negative regulator of SDF-1-CXCR4 signaling in megakaryocytes.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

Selective reduction of JAK2V617F-dependent cell growth by siRNA/shRNA and its reversal by cytokines.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

The significance of digital gene expression profiles

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

Signal transduction by a CD16/CD7/Jak2 fusion protein

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

Detection of aberrant gene expression in CD34+ hematopoietic stem cells from patients with agnogenic myeloid metaplasia using oligonucleotide microarrays

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

Gene expression profiling in polycythaemia vera: overexpression of transcription factor NF-E2.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021

JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.275

7 January 2021